Mesenchymal Stem Cells and Their Extracellular Vesicles: Therapeutic Mechanisms for Blood-Spinal Cord Barrier Repair Following Spinal Cord Injury

Overview

Journal Int J Mol Sci

Publisher MDPI

Specialties Biochemistry
Chemistry
Molecular Biology

Date 2025 Jan 8

PMID 39769223

Authors

Masahito Nakazaki

Takahiro Yokoyama

Karen L Lankford

Ryosuke Hirota

Jeffery D Kocsis

Osamu Honmou

Affiliations

Soon will be listed here.

Abstract

Spinal cord injury (SCI) disrupts the blood-spinal cord barrier (BSCB) exacerbating damage by allowing harmful substances and immune cells to infiltrate spinal neural tissues from the vasculature. This leads to inflammation, oxidative stress, and impaired axonal regeneration. The BSCB, essential for maintaining spinal cord homeostasis, is structurally similar to the blood-brain barrier. Its restoration is a key therapeutic target for improving outcomes in SCI. Mesenchymal stromal/stem cells (MSCs) and their secreted extracellular vesicles (MSC-EVs) have gained attention for their regenerative, immunomodulatory, and anti-inflammatory properties in promoting BSCB repair. MSCs enhance BSCB integrity by improving endothelial-pericyte association, restoring tight junction proteins, and reducing inflammation. MSC-EVs, which deliver bioactive molecules, replicate many of MSCs' therapeutic effects, and offer a promising cell-free alternative. Preclinical studies have shown that both MSCs and MSC-EVs can reduce BSCB permeability, promote vascular stability, and support functional recovery. While MSC therapy is advancing in clinical trials, MSC-EV therapies require further optimization in terms of production, dosing, and delivery protocols. Despite these challenges, both therapeutic approaches represent significant potential for treating SCI by targeting BSCB repair and improving patient outcomes.

References

Overgaard Wichmann T, Kasch H, Dyrskog S, Hoy K, Moller B, Krog J . The inflammatory response and blood-spinal cord barrier integrity in traumatic spinal cord injury: a prospective pilot study. Acta Neurochir (Wien). 2022; 164(12):3143-3153. DOI: 10.1007/s00701-022-05369-6. View

Jia X, Huang G, Wang S, Long M, Tang X, Feng D . Extracellular vesicles derived from mesenchymal stem cells containing microRNA-381 protect against spinal cord injury in a rat model via the BRD4/WNT5A axis. Bone Joint Res. 2021; 10(5):328-339. PMC: 8160032. DOI: 10.1302/2046-3758.105.BJR-2020-0020.R1. View

Magota H, Sasaki M, Kataoka-Sasaki Y, Oka S, Ukai R, Kiyose R . Intravenous infusion of mesenchymal stem cells delays disease progression in the SOD1G93A transgenic amyotrophic lateral sclerosis rat model. Brain Res. 2021; 1757:147296. DOI: 10.1016/j.brainres.2021.147296. View

Versele R, Sevin E, Gosselet F, Fenart L, Candela P . TNF-α and IL-1β Modulate Blood-Brain Barrier Permeability and Decrease Amyloid-β Peptide Efflux in a Human Blood-Brain Barrier Model. Int J Mol Sci. 2022; 23(18). PMC: 9499506. DOI: 10.3390/ijms231810235. View

Lu Y, Zhou Y, Zhang R, Wen L, Wu K, Li Y . Bone Mesenchymal Stem Cell-Derived Extracellular Vesicles Promote Recovery Following Spinal Cord Injury via Improvement of the Integrity of the Blood-Spinal Cord Barrier. Front Neurosci. 2019; 13:209. PMC: 6423165. DOI: 10.3389/fnins.2019.00209. View

Wang X, Gu H, Qin D, Yang L, Huang W, Essandoh K . Exosomal miR-223 Contributes to Mesenchymal Stem Cell-Elicited Cardioprotection in Polymicrobial Sepsis. Sci Rep. 2015; 5:13721. PMC: 4562230. DOI: 10.1038/srep13721. View

Menezes K, Rosa B, Freitas C, Cruz A, de Siqueira Santos R, Nascimento M . Human mesenchymal stromal/stem cells recruit resident pericytes and induce blood vessels maturation to repair experimental spinal cord injury in rats. Sci Rep. 2020; 10(1):19604. PMC: 7658254. DOI: 10.1038/s41598-020-76290-0. View

Salman M, Kitchen P, Halsey A, Wang M, Tornroth-Horsefield S, Conner A . Emerging roles for dynamic aquaporin-4 subcellular relocalization in CNS water homeostasis. Brain. 2021; 145(1):64-75. PMC: 9088512. DOI: 10.1093/brain/awab311. View

Kou M, Huang L, Yang J, Chiang Z, Chen S, Liu J . Mesenchymal stem cell-derived extracellular vesicles for immunomodulation and regeneration: a next generation therapeutic tool?. Cell Death Dis. 2022; 13(7):580. PMC: 9252569. DOI: 10.1038/s41419-022-05034-x. View

10.

Morita T, Sasaki M, Kataoka-Sasaki Y, Nakazaki M, Nagahama H, Oka S . Intravenous infusion of mesenchymal stem cells promotes functional recovery in a model of chronic spinal cord injury. Neuroscience. 2016; 335:221-31. DOI: 10.1016/j.neuroscience.2016.08.037. View

11.

Goritz C, Dias D, Tomilin N, Barbacid M, Shupliakov O, Frisen J . A pericyte origin of spinal cord scar tissue. Science. 2011; 333(6039):238-42. DOI: 10.1126/science.1203165. View

12.

Wang C, Wang M, Xia K, Wang J, Cheng F, Shi K . A bioactive injectable self-healing anti-inflammatory hydrogel with ultralong extracellular vesicles release synergistically enhances motor functional recovery of spinal cord injury. Bioact Mater. 2021; 6(8):2523-2534. PMC: 7873581. DOI: 10.1016/j.bioactmat.2021.01.029. View

13.

Jin L, Li J, Wang K, Xia W, Zhu Z, Wang C . Blood-Spinal Cord Barrier in Spinal Cord Injury: A Review. J Neurotrauma. 2020; 38(9):1203-1224. DOI: 10.1089/neu.2020.7413. View

14.

Tan H, Wang N, Li S, Hong M, Wang X, Feng Y . The Reactive Oxygen Species in Macrophage Polarization: Reflecting Its Dual Role in Progression and Treatment of Human Diseases. Oxid Med Cell Longev. 2016; 2016:2795090. PMC: 4837277. DOI: 10.1155/2016/2795090. View

15.

Kigerl K, Gensel J, Ankeny D, Alexander J, Donnelly D, Popovich P . Identification of two distinct macrophage subsets with divergent effects causing either neurotoxicity or regeneration in the injured mouse spinal cord. J Neurosci. 2009; 29(43):13435-44. PMC: 2788152. DOI: 10.1523/JNEUROSCI.3257-09.2009. View

16.

Zhou R, Li J, Chen Z, Wang R, Shen Y, Zhang R . Pathological hemodynamic changes and leukocyte transmigration disrupt the blood-spinal cord barrier after spinal cord injury. J Neuroinflammation. 2023; 20(1):118. PMC: 10200062. DOI: 10.1186/s12974-023-02787-w. View

17.

Abbott N, Patabendige A, Dolman D, Yusof S, Begley D . Structure and function of the blood-brain barrier. Neurobiol Dis. 2009; 37(1):13-25. DOI: 10.1016/j.nbd.2009.07.030. View

18.

Maggini J, Mirkin G, Bognanni I, Holmberg J, Piazzon I, Nepomnaschy I . Mouse bone marrow-derived mesenchymal stromal cells turn activated macrophages into a regulatory-like profile. PLoS One. 2010; 5(2):e9252. PMC: 2821929. DOI: 10.1371/journal.pone.0009252. View

19.

Park H, Shin J, Kim H, Oh S, Song S, Lee P . Mesenchymal stem cells stabilize the blood-brain barrier through regulation of astrocytes. Stem Cell Res Ther. 2015; 6:187. PMC: 4588687. DOI: 10.1186/s13287-015-0180-4. View

20.

Matsushita T, Lankford K, Arroyo E, Sasaki M, Neyazi M, Radtke C . Diffuse and persistent blood-spinal cord barrier disruption after contusive spinal cord injury rapidly recovers following intravenous infusion of bone marrow mesenchymal stem cells. Exp Neurol. 2015; 267:152-64. DOI: 10.1016/j.expneurol.2015.03.001. View